SIA
DGX icon

SkyView Investment Advisors’s Quest Diagnostics DGX Stock Holding History

SkyView Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4
Closed -$1K – 634
2023
Q2 		$1K Buy
4
+2
+100% +$276 ﹤0.01% 648
2023
Q1 		$0 Buy
+2
New +$286 ﹤0.01% 686
2021
Q3 		– Sell
-105
Closed -$13K – 384
2021
Q2 		$13K Hold
105
– – 0.01% 253
2021
Q1 		$13K Buy
105
+86
+453% +$10.6K 0.01% 261
2020
Q4 		$2K Buy
+19
New +$2.32K ﹤0.01% 272

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SkyView Investment Advisors's DGX Position: Q3 2023 in Review

SkyView Investment Advisors sold out of Quest Diagnostics (DGX) in Q3 2023, closing a stake of 4 shares — an estimated $1K sold.

SkyView Investment Advisors first reported a position in DGX in Q4 2020 and held it in 5 quarters. The position peaked at $13K in Q2 2021. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

  • SkyView Investment Advisors reported no remaining Quest Diagnostics position as of Q3 2023 after selling out during the quarter.
  • SkyView Investment Advisors sold 4 Quest Diagnostics shares in Q3 2023, an estimated $1K.
  • SkyView Investment Advisors first reported a position in Quest Diagnostics in Q4 2020 and held it in 5 quarters.
  • SkyView Investment Advisors's Quest Diagnostics position peaked at $13K in Q2 2021.
  • 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on SkyView Investment Advisors's 13F filing for Q3 2023, filed 17 Nov 2023.